• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

549.65 -19.47 (-3.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 718,031
Open 569.60
Bid (Size) 545.03 (1)
Ask (Size) 700.00 (1)
Prev. Close 569.12
Today's Range 545.02 - 578.26
52wk Range 352.77 - 678.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
14 Analysts Have This To Say About argenx
Today 17:01 EDT
Via Benzinga
Argenx Shares Drop After Q1 Miss, But Retail Traders Call Sub-$550 ‘An Absolute Steal’
May 08, 2025
Despite the Q1 miss, management reiterated confidence in its long-term “Vision 2030” strategy, highlighting strong Vyvgart uptake in gMG and CIDP and the recent U.S. approval of a self-injection... 
Via Stocktwits
Topics Earnings
Exposures Financial

Performance

YTD
-11.4%
-11.4%
1 Month
+0.1%
+0.1%
3 Month
-16.5%
-16.5%
6 Month
-7.1%
-7.1%
1 Year
+42.4%
+42.4%

More News

Read More
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
May 08, 2025
Via Benzinga
Exposures Fossil Fuels
Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble
May 08, 2025
Via Investor's Business Daily
Earnings Scheduled For May 8, 2025
May 08, 2025
Via Benzinga
argenx Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From argenx SE
Via GlobeNewswire
A Look Into argenx Inc's Price Over Earnings
May 07, 2025
Via Benzinga
P/E Ratio Insights for argenx
April 29, 2025
Via Benzinga
argenx to Present at BofA Securities 2025 Health Care Conference
May 06, 2025
From argenx SE
Via GlobeNewswire
argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
May 01, 2025
From argenx SE
Via GlobeNewswire
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
April 28, 2025
From argenx SE
Via GlobeNewswire
What's Driving the Market Sentiment Around argenx?
April 21, 2025
Via Benzinga
Does ARGENX SE - ADR (NASDAQ:ARGX) meet the Minervini criteria?
April 26, 2025
Via Chartmill
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
April 21, 2025
Via Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
April 18, 2025
Via Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
Via Benzinga
Exposures Product Safety
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
April 11, 2025
From argenx SE
Via GlobeNewswire
Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug
April 11, 2025
Via Investor's Business Daily
Exposures Product Safety
What 11 Analyst Ratings Have To Say About argenx
April 11, 2025
Via Benzinga
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
April 11, 2025
Via Benzinga
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
April 10, 2025
From argenx SE
Via GlobeNewswire
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
Via Benzinga
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
April 08, 2025
Via Benzinga
argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP
April 08, 2025
From argenx SE
Via GlobeNewswire
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
March 31, 2025
Via Benzinga

Frequently Asked Questions

Is argenx SE - American Depositary Shares publicly traded?
Yes, argenx SE - American Depositary Shares is publicly traded.
What exchange does argenx SE - American Depositary Shares trade on?
argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for argenx SE - American Depositary Shares?
The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
What is the current price of argenx SE - American Depositary Shares?
The current price of argenx SE - American Depositary Shares is 549.65
When was argenx SE - American Depositary Shares last traded?
The last trade of argenx SE - American Depositary Shares was at 05/09/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap